Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1749 USD | -4.58% | -2.24% | -19.10% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 43.87M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.59
x | P/E ratio 2025 * |
-1.59
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | -4.58% | ||
1 week | -2.24% | ||
Current month | -5.82% | ||
1 month | -17.81% | ||
3 months | -12.77% | ||
6 months | -23.96% | ||
Current year | -19.10% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.1749 | -4.58% | 1,456,081 |
24-05-02 | 0.1833 | +0.38% | 854,661 |
24-05-01 | 0.1826 | -1.67% | 1,575,975 |
24-04-30 | 0.1857 | +1.20% | 1,116,102 |
24-04-29 | 0.1835 | +2.57% | 805,741 |
Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.10% | 43.87M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- MTNB Stock